RICH.BA
Price:
$1590
Market Cap:
$128.39B
Laboratorios Richmond S.A.C.I.F. is a pharmaceutical firm focused on the development and production of a diverse range of medicinal products. Their extensive portfolio includes antiretroviral treatments for human immunodeficiency virus (HIV), as well as therapies for oncology and oncohematology conditions. The company also supplies various cardiometabolic medications, such as those for blood pressure reduction, cholesterol management, platelet aggregation inhibition, and blood sugar control. Additionally, they produce neurological and psychiatric drugs, covering analgesics, antipsychotics, antidepressants, anti-dementia agents, antiepileptics, hypnotics, and treatments for multiple sclerosis...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2025-07-18
Stock Exchange
BUE
Ticker
RICH.BA
According to Laboratorios Richmond S.A.C.I.F.’s latest financial reports and current stock price. The company's current PE Ratio is 6.91. This represents a change of -15803.43% compared to the average of -0.04 of the last 4 quarters.
The mean historical PE Ratio of Laboratorios Richmond S.A.C.I.F. over the last ten years is 25.51. The current 6.91 PE Ratio has changed 2.61% with respect to the historical average. Over the past ten years (40 quarters), RICH.BA's PE Ratio was at its highest in in the June 2019 quarter at 316.13. The PE Ratio was at its lowest in in the March 2016 quarter at -4204.55.
Average
25.51
Median
15.56
Minimum
-8.76
Maximum
61.75
Discovering the peaks and valleys of Laboratorios Richmond S.A.C.I.F. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 749.64%
Maximum Annual PE Ratio = 61.75
Minimum Annual Increase = -775.68%
Minimum Annual PE Ratio = -8.76
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 51.65 | 749.64% |
| 2024 | 6.08 | -216.94% |
| 2023 | -5.20 | -108.42% |
| 2022 | 61.75 | 296.90% |
| 2021 | 15.56 | 22.44% |
| 2020 | 12.71 | -78.53% |
| 2019 | 59.18 | -775.68% |
| 2018 | -8.76 | -123.91% |
The current PE Ratio of Laboratorios Richmond S.A.C.I.F. (RICH.BA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
17.51
5-year avg
25.97
10-year avg
25.51
Laboratorios Richmond S.A.C.I.F.’s PE Ratio is
| Company | PE Ratio | Market cap |
|---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Laboratorios Richmond S.A.C.I.F. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Laboratorios Richmond S.A.C.I.F. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Laboratorios Richmond S.A.C.I.F.'s PE Ratio?
How is the PE Ratio calculated for Laboratorios Richmond S.A.C.I.F. (RICH.BA)?
What is the highest PE Ratio for Laboratorios Richmond S.A.C.I.F. (RICH.BA)?
What is the 3-year average PE Ratio for Laboratorios Richmond S.A.C.I.F. (RICH.BA)?
What is the 5-year average PE Ratio for Laboratorios Richmond S.A.C.I.F. (RICH.BA)?
How does the current PE Ratio for Laboratorios Richmond S.A.C.I.F. (RICH.BA) compare to its historical average?